Linden Thomas Advisory Services LLC boosted its position in shares of Veeva Systems Inc. (NYSE:VEEV – Free Report) by 1.0% during the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 12,088 shares of the technology company’s stock after purchasing an additional 116 shares during the quarter. Linden Thomas Advisory Services LLC’s holdings in Veeva Systems were worth $2,542,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also bought and sold shares of the company. Dimensional Fund Advisors LP increased its position in shares of Veeva Systems by 26.2% during the second quarter. Dimensional Fund Advisors LP now owns 378,380 shares of the technology company’s stock valued at $69,259,000 after acquiring an additional 78,654 shares in the last quarter. Pacer Advisors Inc. boosted its stake in Veeva Systems by 31.4% during the 2nd quarter. Pacer Advisors Inc. now owns 5,688 shares of the technology company’s stock valued at $1,041,000 after purchasing an additional 1,359 shares during the last quarter. Bank of Montreal Can increased its holdings in shares of Veeva Systems by 272.7% in the 2nd quarter. Bank of Montreal Can now owns 152,697 shares of the technology company’s stock worth $28,463,000 after purchasing an additional 111,724 shares in the last quarter. Marshall Wace LLP purchased a new position in shares of Veeva Systems in the second quarter worth $21,769,000. Finally, AQR Capital Management LLC lifted its holdings in shares of Veeva Systems by 48.0% during the second quarter. AQR Capital Management LLC now owns 444,477 shares of the technology company’s stock valued at $81,344,000 after purchasing an additional 144,104 shares in the last quarter. 88.20% of the stock is currently owned by institutional investors.
Insider Activity at Veeva Systems
In other news, SVP Jonathan Faddis sold 1,694 shares of the stock in a transaction that occurred on Wednesday, December 4th. The stock was sold at an average price of $230.30, for a total transaction of $390,128.20. Following the completion of the transaction, the senior vice president now directly owns 8,061 shares in the company, valued at approximately $1,856,448.30. This represents a 17.37 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Thomas D. Schwenger sold 1,126 shares of the business’s stock in a transaction on Friday, November 8th. The stock was sold at an average price of $240.01, for a total transaction of $270,251.26. Following the completion of the sale, the insider now owns 27,013 shares in the company, valued at $6,483,390.13. This represents a 4.00 % decrease in their position. The disclosure for this sale can be found here. 10.50% of the stock is owned by corporate insiders.
Analyst Upgrades and Downgrades
View Our Latest Report on Veeva Systems
Veeva Systems Stock Up 0.2 %
NYSE:VEEV opened at $223.37 on Friday. The business’s 50-day simple moving average is $221.63 and its two-hundred day simple moving average is $210.89. Veeva Systems Inc. has a 52 week low of $170.25 and a 52 week high of $258.93. The stock has a market cap of $36.26 billion, a PE ratio of 55.15, a P/E/G ratio of 2.01 and a beta of 0.84.
Veeva Systems Company Profile
Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.
See Also
- Five stocks we like better than Veeva Systems
- What Are Dividend Achievers? An Introduction
- Why Traders Are Buying the Dip on Johnson & Johnson Stock
- Want to Profit on the Downtrend? Downtrends, Explained.
- MarketBeat Week in Review – 01/20 – 01/24
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Netflix Stock Positioned for Explosive Growth in 2025
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.